Report Categories
View AllRecent Articles
View All
Advanced Micro Devices Inc AMD Rides AI CPU Demand Tailwind Amid Peer Intels INTC Comeback Narrative
Alphabet Inc GOOGL AI Transformation Propels Tech Giant to New Heights
Walker WD Stock Should You Invest Grinds Higher 20260420
WFCZ Wells investors seek updated net interest margin guidance in latest quarterly earnings release
HA HASI Stock Underperform Rating RangeBound 20260420
The quiet strength in Addus ADUS business model In Focus 20260508
Linde plc LIN Sixth Consecutive Ethics Recognition Reinforces ESG Credentials Amid Premium Valuation and Bullish Momentum
STRRP Star shares rally despite huge Q4 earnings miss investors shrug at losses focus on yield
How FTAI FTAIM insider activity aligns with performance FTAI posts 152 negative EPS surprise falling short of estimates
Caesars CZR Q1 2026 Results Fall Short EPS 048 Revenue NA
Broadening Inflation Pressures Emerge Beyond Iran and Oil New Data Shows
Novanta NOVT Q1 2026 Earnings Why the Beat Matters
InMed INM Q3 2025 Earnings EPS 194 In Line with Estimates
Kwek Leng Peck Appointed ViceChairman of City Developments Limited in Board Restructuring
Frontier FNUC Stock Analysis Climbs 196 Eyes on 218 20260520
Financial Abuse TV Presenter Ruth Dodsworth Reveals ExHusband Cut Off Access to Her Own Funds
Adobe ADBE Slips 064 Testing 24070 Support 20260520
SP 500 Edges Higher as Healthcare and Tech Lead Gains
President Trump Delays AI Executive Order Citing Concerns Over Potential Obstacles to Innovation
ADP Private Payrolls Rise 109000 in April Surpassing Expectations Signaling Labor Market Resilience
Consumer Sentiment Plunges to Record Low in May Amid USIran Conflict and Inflation Concerns
Trainline Upgrades FullYear Guidance for Second Time This Year
Goldman Sachs CEO David Solomon AIDriven Job Loss Fears Overblown May Create New Opportunities
WPP Q4 2025 Earnings EPS Beats Estimates Shares Edge Higher Amid Cautious Ad Market
GSK Q1 2026 Earnings Solid EPS Beat Amid Mixed Market Sentiment
AKTS Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development
PDS Q1 2026 Earnings EPS Falls Sharply Below Estimates Stock Edges Higher
FIGS Q1 2026 Earnings Strong EPS Surprise Highlights Margin Improvement
Protagonist Therapeutics PTGX Hovering Near Resistance After Modest Pullback
Expand Energy EXE Nears Resistance After Modest Decline
Main Street Capital MAIN Climbs 052 Nearing Key Resistance Zone
Liminatus Pharma LIMN Shares Slide 325 as Selling Pressure Mounts Near Support
External Links
TWLV Twelve outlines emerging market investment priorities as core strategic focus in its latest quarterly earnings release
US April Payrolls Surge Beyond Expectations Yet Underlying Signals Raise Caution
Evaxion Q1 2026 Earnings EPS Widely Misses Estimates as ClinicalStage Biotech Continues Pipeline Investment